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 Jefferson Medical College 
Department of Health Policy 
 
Annual Report 2004-2005 
 
 
 
 
Chair:     David B. Nash, MD, MBA 
     The Dr. Raymond C. and Doris N. Grandon 
     Professor of Health Policy 
 
Director of Education:  Barbara Bozarth, MSEd 
 
Director of Research:  Neil I. Goldfarb (faculty appointment pending) 
 
Associate Director of Research: Laura Pizzi, PharmD, MPH (faculty appointment 
pending) 
 
 
Other Faculty Members:   
• Albert Crawford, MBA, MSIS, PhD, Assistant Professor 
• Christine Hartmann, MSS, PhD, Assistant Professor 
• Jennifer Lofland, PharmD, MPH, PhD, Assistant Professor of Medicine (Health  
Policy appointment pending)  
• Vittorio Maio, PharmD, MS, MSPH, Research Assistant Professor 
• Christopher Sciamanna, MD, MPH, Associate Professor 
• Kenneth D. Smith, PhD (appointment pending) 
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I. General Background 
 
1) Main responsibilities 
 
In January of 2004, with unanimous support from the Executive Council of JMC, the 
Board of Trustees of TJU approved the creation of the Department of Health Policy, 
building on the 14-year history of the Office of Health Policy and Clinical Outcomes. 
Jefferson now joins an elite handful of medical schools across the country with a bona fide 
Department of Health Policy.  Jefferson is also one of only a half dozen medical schools in 
the United States with an endowed chair in this field.   
 
The Department’s principal responsibility is to serve as the locus for health policy 
activities across the Medical College.  “Health Policy” is broadly defined to encompass 
quality measurement and improvement, traditional health services research to support 
health care delivery and financing decisions, pharmacoeconomics, and public health.  The 
Department’s mission statement is: 
 
The Department of Health Policy of Jefferson Medical College is committed to 
conducting research and education programs which contribute to the quality, 
safety, and cost-effectiveness of health care.  The Department’s activities are meant 
to inform decisions made by government policy makers, providers, payers, and 
other health system stakeholders, about how best to deliver and finance care in 
order to improve the health of the public.   
 
This mission is implemented through three main strategies -- education, research and 
policy consulting services – which are described further in this report. 
 
2) Evaluating Departmental Performance 
 
The Department’s research and education activities emphasize the need for performance 
measurement and improvement, and the Department has established a set of performance 
indicators against which current and future performance can be judged.  As an academic 
department, traditional quantifiable measures of performance include number and total 
amount of grants, ability to continue to be self-sustaining, number of publications in peer 
reviewed journals, number of presentations at scientific meetings, number of faculty and 
other research professionals, and number of educational programs and “students” exposed 
to these programs.    
 
A critically important non-traditional, difficult to quantify, performance measure for a 
health policy department, is impact of research and education programs, as reflected by 
changes in local, state, and national policies, and changes in care processes and outcomes.  
National visibility and recognition as reflected in the media, requests to engage speakers, 
and invitations to participate on task forces and committees help to reflect this policy 
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impact factor.  Ultimately, these aspects of performance should be reflected in some of the 
measures listed above (e.g. ability to attract grant funding and number of publications).   
 
3) Present strengths and weaknesses 
 
In the past year, since gaining departmental status, significant progress has been made in 
furthering the Department’s mission.  The Department has an excellent national reputation 
despite this short tenure as a department, and is recognized as a source of timely and high-
quality research, outstanding educational offerings and excellent training, especially in the 
area of outcomes research.   
 
a) Education 
 
The Department has a strong team for designing, administering and evaluating education 
programs on all levels of student professional education.  Department faculty remain 
committed to working with undergraduate and graduate medical education program 
directors to seek opportunities to incorporate principles of evidence-based medicine, 
performance measurement and improvement, care and disease management, and other 
“non-traditional” aspects of care delivery and practice administration into the curriculum.  
We are actively engaged in teaching the tenets of the two key ACGME competencies, 
namely, systems based practice and practice-based learning.  As described further below, 
in the education section, at present, the Department’s interaction with other educators and 
with Jefferson medical students and residents, is limited to a few small aspects of the 
overall curriculum.    
 
b) Research 
 
The Department has an active research program and is fully grant-supported.  Historically, 
as an “Office” of health policy, the Department was not able to confer faculty status to 
non-clinician researchers, or attract researchers for a faculty career trajectory.  The number 
of research grants therefore was limited by the need to involve the Chair as Principal 
Investigator on almost all new research activities, despite the presence of several highly-
qualified research staff members.  As these staff members seek and are approved for 
faculty positions, the scope and funding of the research program will continue to increase.  
This transformation has begun during the past academic year.   The funding portfolio, 
which has relied more than 50% on industry-sponsored grants, should also increasingly 
include government and foundation sources of support. 
 
c) Patient Care (not applicable) 
 
4) Two year plan for changes and innovations 
 
Efforts are underway to further strengthen the departmental faculty.  Recruitment of at 
least two additional faculty members will be a priority for the 2005-2006 year, including 
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an additional Associate Director of Research.  The Department’s faculty also will continue 
to be bolstered by offering secondary appointments to Jefferson Medical College faculty in 
other departments who have an expressed and demonstrated interest in health policy 
research and education.  In addition, the Department has now developed a “Senior 
Scholars” program for researchers and educators outside of the JMC community who 
would like to establish an affiliation with the Department.  Criteria for the Senior Scholars 
program and application materials also have been developed, and over 45 applications 
have been approved.  A list of current Senior Scholars may be found on the Department’s 
web site, www.jefferson.edu/dhp. 
 
This Senior Scholars program already has led to several new funding opportunities and 
educational program offerings, and it is expected to continue to serve as a vital resource for 
furthering the department’s activities. 
 
A related goal for development over the next two years is to identify, strengthen, and 
market areas of expertise within the Department, while maintaining our historical breadth 
of activity.  The Department is recognized nationally for its health policy work; as we 
move forward, we will seek to be recognized as having in-depth expertise in select 
specialty areas as well.  Examples of foci for activity include: development, 
implementation, and evaluation of ambulatory quality measures; employer strategies for 
quality, value and productivity improvement; economic evaluation of drugs and devices; 
improving patient-provider communications and the consumer’s role in health care; and, 
evaluation of disease management programs and services. 
 
5) Needed resources 
 
Becoming a Department creates additional expectations of, and resource needs for Health 
Policy.  In recognition of the administrative challenges associated with becoming a 
Department, a full-time Grants Manager was hired in late 2003, and in July of 2005, the 
Department added an appropriately qualified Departmental Administrator to the leadership 
team.   
 
The Department historically has grown from a two-person to a 25 person operation, 
without relying on any additional core funds from the Medical College or Hospital.  In 
order to implement plans for growth in both the research and education areas, the 
Department would ideally want to obtain some commitment of core support for 
recruitment of young faculty, to foster their ability to develop fundable research programs 
and areas of expertise, until they become fully self-sufficient.  The Department also would 
benefit from access to additional grant seeking and writing support staff, to free senior 
faculty for more creative work and for mentoring of junior members of the department.  
Additional office space is the other resource need which will have to be addressed in the 
coming year.  The Department’s current space in the Curtis Building is at capacity, and the 
Department already is borrowing space from other centers on campus. 
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6) Plan for obtaining needed resources 
 
Since the Department currently receives a minimal amount of core funding (as a 
percentage of overall operating budget), sources of philanthropic support need to be 
sought, in concert with Institutional Advancement.  Unlike clinical departments, Health 
Policy has a lack of connectivity to grateful patients, and must seek other sources of 
philanthropy, such as alumni with a strong interest in the policy agenda, and corporate 
foundations.   
 
The plan for obtaining additional resources also includes expanding relations with the 
dozens of funding sources already familiar with the activities of the Department.  A 
broader public affairs related initiative to familiarize others with the Department’s 
capabilities is underway.  Recruiting for key open positions is also proceeding.  Returning 
to funding sources for extensions of current contracts, and new program support, in both 
the research and educational spheres, is a key strategy for obtaining additional support. 
 
II. Departmental Programs 
 
A. Education 
 
1. Medical Students 
 
a. MP21 
 
For the eleventh consecutive year, Daniel Z. Louis, MS, Managing Director of the Center 
for Research in Medical Education and Health Care and the Chairman of the Department 
of Health Policy, taught “An Introduction to the Health Care System”, part of the JMC 
Medical Practice in the 21st Century course.  Based on the course evaluations, these 15 
contact hours proved to be extremely successful.  Topics, as in previous years, included 
health care financing, organization of health services, and the varying structures of 
managed care systems. 
 
b. Interclerkship Day 
 
In January 2004, the Department organized and presented the 2nd JMC Interclerkship Day 
program, Improving Patient Safety.  Featuring three nationally prominent experts,  James 
P. Bagian (JMC ‘ 77), inaugural Director of the Veterans Administration National Center 
for Patient Safety (NCPS), Peter J. Pronovost, MD, PhD, Director of the Quality and 
Safety Research Group and the Medical Director for the Center for Innovations in Quality 
Patient Care at Johns Hopkins University, and David P. Stevens, MD, founding Director of 
the AAMC Institute for Improving Clinical Care, the program addressed many of the 
barriers to incorporating patient safety and quality improvement tools in the inpatient 
setting, prompted students to think of ways in which the culture could be changed at 
Jefferson to promote greater patient safety, and emphasized the need to utilize a systems 
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approach with full support from leadership, management, providers, and staff to 
comprehensively address and reduce problems and errors.  Outcomes of the program are 
being organized for publication in a scholarly journal. 
 
c. Summer Internship 
 
The Department continued to serve as a training site for medical students who completed 
their freshman year and were selected to participate in the Dean’s summer internship 
program.  This year’s (2004) recipient, Jeffrey Clough, researched topics in medical 
education and health policy, which culminated in two national presentations, two peer-
reviewed publications, and a web-based teaching tool on the new ACGME competencies. 
 
d. Academic Year Internship 
 
The Department has gained a reputation as a training site for medical students who are 
completing requirements for the MBA program.  This year, Jason Korenblit, contributed to 
multiple department projects while he finishes his coursework at Widener University.  The 
Department also welcomed Ross Breitbart, a second year D.O./M.S. in health policy 
student at Philadelphia College of Osteopathic Medicine and the University of the Sciences 
in Philadelphia, as an academic intern. 
 
e. Policy Elective 
 
In March of the JMC senior year, the Chairman conducts a one-month graduate-style 
elective in health policy.  The year students read From Chaos to Care by David Lawrence 
and Managing Quality of Care in a Cost Focused Environment co-edited by the Chair.  
These two books were critically reviewed by the students with the Chair’s guidance.  The 
Chair also continues to serve as the faculty advisor of the JMC student club, “Physicians of 
Tomorrow”.  
 
f. MD/MBA Program 
 
It is widely acknowledged that physician training in management skills must improve.  
Indeed, a growing body of literature specific to the physician manager is available and is 
actively tracked and contributed to by the Department.  Currently eight JMC students are 
enrolled in the unique five-year MD/MBA training program, co-directed by JMC through 
the Department of Health Policy and Widener University in Chester, Pennsylvania.  This 
year saw the graduation of the sixth cohort of students from the combined degree program.  
Not surprisingly, the JMC MD/MBA students have proven to be academic standouts 
within both the undergraduate medical and graduate business curricula.  The students, 
faculty, and administrators responsible for directing this program meet twice during the 
academic year to review progress and make plans for future enrollees.   
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2. Graduate Students 
 
a. GC515 - “Quality Measurement and Outcomes Analysis in Health Care” 
 
This course, cross-listed with University of the Sciences in Philadelphia, now in its fifth 
year, is led by Neil Goldfarb, Director of Research, and the Chair.  Guest faculty are drawn 
from the Department, and the Jefferson and Delaware Valley communities. 
 
b. GC650 – “Economic Evaluation of Health Care Technologies”  
 
This course (formerly titled “Pharmacoeconomis”) is led by Laura Pizzi, PharmD, 
Associate Director of Research and Neil Goldfarb, Director of Research. 
 
c. PH706 – “Health Services Research Methodology” 
 
This course was introduced in the spring of 2004, under the leadership of Jennifer Lofland, 
PharmD, MPH, PhD.  Many of the individual sessions are taught by members of the 
Department’s research staff and other guest faculty.   
 
d. Master of Science in Public Health (MSPH) 
 
During the past academic year, the Chair continued as the co-director of the Master of 
Science Program in Public Health (MSPH).  The Chair shares these responsibilities with 
Richard Wender, MD, Alumni Professor and Chairman, Department of Family Medicine.  
The MSPH is a 40 credit program designed to meet the needs of working professionals.  A 
thesis and field project are required.  Currently, 50 students from a variety of backgrounds 
are enrolled.  The first cohort of 4 students graduated in June 2005, including two members 
of the Department of Health Policy. 
 
The co-directors created and chair the monthly MSPH Steering Committee, which 
provides overall strategic guidance for the MSPH program and is responsible for seeking 
formal national accreditation.  This group is also responsible for organizing and 
continuously updating the curriculum and interfacing with the large number of community-
based clerkship sites for the students.  Jennifer Lofland, PharmD, MPH, PhD, a 
Department of Health Policy staff member, serves as the program manager for curriculum 
development. 
 
The co-directors also organized an Advisory Group, which is composed of more than a 
dozen local leaders who volunteer their time in support of the field projects for students.  
The Advisory Group meets annually and hosts the annual Faculty-Student Open House. 
Laura Pizzi, PharmD, MPH, is a member of this Advisory Group. 
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3. Research and Clinical Fellows 
 
A. Outcomes Research Fellowship Programs  
 
The Department continues to serve as a training site for outcomes research fellowships.  
During 2004-2005, fellowships were sponsored by Janssen Pharmaceutica (now Ortho-
McNeil Janssen Scientific Affairs, LLC) and GlaxoSmithKline.  For the 2005-2006 an 
additional fellowship position has been funded by Cephalon.  Fellows who participate in 
this program are PharmD or MD trained clinicians.  Collaborations such as these have 
resulted in numerous published studies and posters for presentations as national meetings.  
In May 2005, the Chair hosted the Fifth Annual National Fellowship Advisory Council, a 
group of more than 28 former Department fellows, in Washington, DC.  The National 
Advisory Council provides overall strategic direction for the fellowship program.  Alumni 
of the fellowship program are often a source of research support for the Department. 
 
B. Centers for Medicare and Medicaid Services Scholar 
 
The Department served as a site for the nationally prestigious Centers for Medicare and 
Medicaid Services (CMS) Health Policy Scholars Program.  Richard Stefanacci, DO, 
MGH, MBA, CMD, one of five national scholars, completed his experience with the 
Department in June 2004.  Dr. Stefannacci subsequently went on to become the founding 
director of a nascent center for health policy at the University of the Sciences (USP) in 
Philadelphia. 
 
4. Residents 
 
 A. “From Residency to Reality” 
 
In September 2004, Pfizer, Inc. sponsored, From Residency to Reality, a one-day 
conference for medical residents in the Philadelphia area.   The conference provided 
opportunities for residents and fellows to discuss issues that focused on physicians as 
employees.  Keynote speakers included Timothy Brigham, PhD, Associate Dean, 
Organizational Development, Chief of Staff, Jefferson Medical College; Elizabeth Dow, 
President, LEADERSHIP, Inc.; Wiley Souba, MD, ScD, MBA, Chairman, Department of 
Surgery, Penn State College of Medicine.  After presentations by the keynotes, residents 
had the opportunity to attend workshops on resilience training; effective job searching; 
maintaining the Osler tradition; avoiding professional liability; financial planning; and, 
teaching the teacher. 
 
B. Residency training 
 
The Chairman continues to be involved in clinical training through his outpatient practice 
activities and annual time spent on the teaching service at TJUH.   Dr. Nash serves as an 
advisor to the Residency Program Directors in Internal Medicine as they plan their pay for 
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performance program.  He also lectures several times during the residency noon 
conference program. 
 
5. Other Educational Programs and Audiences 
 
a. Asthma 
 
1. The Department continued its work with Genentech in examining anti-IgE therapy 
for moderate to severe asthma patients.  The focus of 2004-2005 was the completion of a 
series of three web casts targeted to physicians and featuring nationally recognized 
pulmonologists, allergists, and immunologists who addressed the clinical, managed care, 
and Medicaid issues.  In addition, the Department assisted with the production of a clinical 
news brief that highlighted the January 2004 consensus panel recommendations and 
prepared a clinical monograph approved for continuing education. 
 
2. Merck sales representatives and product managers completed a full day clinical 
practicum on asthma and allergic rhinitis.  As part of this program, the participants toured 
the pulmonary lab, experienced pulmonary function tests, were exposed to laboratory 
specimens, and interacted with primary care physicians and specialists. 
 
b. The Medicare Modernization Act of 2003: the Stakeholders' Perspectives 
 
The 10th Annual Summer Seminar featured the leaders of the American Association of 
Retired Persons (AARP), Federation of American Hospitals (FAH), American Health 
Quality Association (AHQA), and Pharmacy Research and Manufacturer's Association 
(PhRMA) who presented the official position of their respective organizations. Following 
the presentations, a panel composed of representatives from Schering Plough Corporation, 
Bristol-Myers Squibb Company, AstraZeneca, and Aventis Pharmaceuticals asked 
questions, commented on specific points, and raised issues that stimulated thinking by the 
audience and speakers.  
 
c. Vaccines 
 
GlaxoSmithKline sales representatives practiced their detailing skills with a simulated 
medical office team composed of a family practitioner, nurse, office manager, and 
pediatrician.  This experience provided the representatives with insight into the different 
roles and perspectives of the various members within an office setting. 
 
Later in their training, the sales representatives were exposed to an immunization specialist 
from the Pennsylvania Department of Health who discussed how vaccines are used in the 
Philadelphia area from a public health perspective (child and adult schedules).  Included in 
this program was an infectious disease specialist who presented case studies on the use of 
vaccines in the hospital. 
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d. Anti-fungals 
 
Bayer pharmaceutical sales representatives experienced a one day clinical practicum on the 
appropriate use of anti-fungals.  The day included presentations by experts in the study of 
urology, infectious diseases, microbiology, critical care, and emergency medicine. 
 
e. Atypical Anti-psychotics 
The Department serves as host and the Chairman as facilitator for the ongoing Atypical 
Anti-psychotics Advisory Board supported by Bristol Myers Squibb. The Board, 
composed of nationally recognized experts in the fields of psychiatry, Medicaid, and 
managed care, meet semi-annually to address new findings in the field. 
 
f. OTC Statins 
 
In its efforts to move Mevacor from a prescription to OTC statin, J&J Merck contracted 
with the Department to gather feedback on principle managed care challenges, specifically 
the operational challenges on making Mevacor OTC work in a managed care setting.  The 
Managed Care Advisory Board, composed of twelve managed care organizations, 
discussed the tracking, financial, and physician education issues that would need attention 
if Mevacor were approved for OTC.  A major article and interview with the chair appeared 
in Managed Care, November 2004. 
 
g. Technology Task Force 
 
GetWellNetwork, a provider of interactive patient care solutions, with the assistance of the 
Department of Health Policy, organized a task force of client users to identify common 
needs and goals and to establish a research agenda (see Research)  that will help each 
institution fulfill its mission.  The task force serves as the core for future advisory board 
users’ meetings, where users will have the opportunity to exchange ideas and explore the 
potential uses of GWN. 
 
h. Adherence and Persistence 
 
The Department of Health Policy and GlaxoSmithKline founded The National Advisory 
Board on Adherence and Persistence,  the purpose of which was to draft a list of 
recommendations regarding adherence and persistence in order to develop a consensus 
statement on future directions for related healthcare research and policy.  Subsequent to 
The National Advisory Board meeting were five Special Issues Boards, regionally 
convened groups of employers who addressed the issues associated with adherence and 
persistence in their employee populations.  The final product of the five board meetings is 
a one hour webcast, hosted by the Chair of the Department, featuring national policy 
experts in the area of adherence and persistence. 
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i. Smoking Cessation 
 
a. The Department, as a subcontractor to Buckley Global Communications, organized 
a one-day program to educate physicians, nurse practitioner, physician assistants, 
pharmacists, and other healthcare professionals on their role in promoting smoking 
cessation among their patient populations.  Funded by a grant from the American Cancer 
Society, Pennsylvania Division and Pennsylvania Department of Health, the program 
highlighted Jefferson physician and Chairman, Department of Family Medicine, Richard 
Wender, MD, President-elect of the American Cancer Society, as well as other nationally 
notable experts. 
 
b. The Department, as a subcontractor to Buckley Global Communications, organized 
a web-based tool to educate physicians, nurse practitioner, physician assistants, 
pharmacists, and other healthcare professionals on their role in promoting smoking 
cessation among their patient populations.  The website (www.mdhelpquit.org) is 
organized into three components:  pre assessment, presentation of material, post 
assessment.  The assessments are designed to examine the impact of this educational 
intervention on physician behavior.  A number of Jefferson physicians are featured in this 
web-based activity. 
 
j. Grandon Lecture 
 
The Honorable Paul O’Neill, former Secretary of Treasury and founder of the Pittsburgh 
Regional Health Initiative, delivered the 14th Annual Raymond C. Grandon Lectureship 
this year.  His focus was on “Aspiring to Be Perfect” by reducing error and improving the 
safety of health care. 
 
k. Demonstrating the Value of Data Warehouses 
Data warehouses, such as “Centricity” from GE Medical Systems, integrate and store 
clinical data and create a rich resource that allows healthcare providers and other industry 
interest groups to observe care trends, outcomes and practices.  The need for data 
warehouses is underscored by the National Health Information Infrastructure (NHII), an 
initiative set forth by the United States government, which provides evidence of the 
recognized significance of information systems in the improvement of the delivery of 
health care.  Over 80 interested healthcare professionals met to hear leaders in academia, 
clinical practice, and industry discuss examples of how a data set is utilized for quality 
improvement and safety studies and how data warehouses can be used in the future to 
promote evidence-based patient care, health outcomes research and pharmacovigilance. 
 
l. Jefferson Industry Advisory Council (JIAC) 
 
JIAC is an organization, founded by the Office of CME and the Department of Health 
Policy, of concerned physicians, biotechnology and pharmaceutical industry leaders, and 
research and continuing education directors.  The mission of the organization is to promote 
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ethical standards of behavior within the medical-academic communities at Jefferson, 
specifically in our interactions with industry.  This year, JIAC hosted two events.  In 
November, Arnold S. Relman, MD, Editor-in-Chief Emeritus, New England Journal of 
Medicine, presented on the intrusion of commerce into medical professionalism and CME.  
Following Dr. Relman, James G. Sheehan, Esq., Chief, Civil Division, U.S. Department of 
Justice, U.S. Attorney, Eastern District, Pennsylvania discussed fraud and abuse issues 
within the healthcare industry including compliance and preventive measures for industry-
academia interactions.  In June 2005, JIAC hosted Synergy through Collaboration, 
featuring keynote, Paul T. Antony, MD, MPH, Chief Medical Officer, Pharmaceutical 
Research and Manufacturers of America (PhRMA) who addressed the topic, Academia and 
the Pharmaceutical Industry Working Together.  A panel of industry leaders provided their 
perspective on how the pharmaceutical industry is reacting to the issue of collaboration and 
partnership in the academic medical community. 
 
m. Osteoporosis 
 
This program was designed for newly hired Merck sales representatives with no prior 
healthcare experience and who call on those primary care physicians who refer patients to 
rheumatology and/or gynecology.  The goal was to prepare the sales representatives for the 
complex and dynamic healthcare environment by providing hands-on experience and gain 
understanding where products fit and how they are utilized.  Participants were exposed to 
the hospital organization, the responsibilities of the key personnel within each division, 
and the interdisciplinary approaches to diagnosis of disease states. 
 
n. Disease Management Colloquium 
 
The Department of Health Policy once again hosted the Disease Management Colloquium, 
the only executive education course on the role of disease management in Medicare, 
Medicaid, healthcare cost efficiency, quality and medical errors reduction, on the Jefferson 
campus. Following Dr. Barchi’s welcome to Jefferson to the 300 attendees, sixty national 
experts in disease management presented updates in the field. During the four day 
program, the Disease Management Editorial Board and the Biotechnology Editorial Boards 
met for their annual dinner and business meetings. 
 
o. Health Policy Forum 
 
 The Department continued to conduct the Health Policy Forum, now in its fifteenth 
year.  The Forum has become a fixture in the scholarly life of the University.  It meets on 
the second Wednesday morning of every month (except August) and provides an 
opportunity for all Jeffersonians and area professionals interested in health policy to 
congregate and share their research experiences.  This past year, the Department sponsored 
such guests as Barry Furrow, JD, Director, The Health Law Institute, Widener University 
School of Law, Maulik Joshi, DrPH, President and CEO, Delmarva Foundation for 
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Medical Care, and Steven Lawrence, Director of Research, The Foundation Center.  
Attendance at the Forum more than doubled in the past year. 
 
p. Enduring Materials 
 
In addition to overseeing the publications of the Department, which are addressed later in 
this report, the education team is responsible for preparing manuscripts.   Supplements, 
newsletter articles, monographs, and journal articles serve as enduring materials for the 
proceedings of key meetings (e.g., The Health of Healthcare, McKesson Executive 
Summit, Disease Management, Winter 2004), clinical discussions of new treatments, and 
presentations of national policy issues.  The Department has three medical writers who 
regularly attend local, regional, and national meetings to report on important issues and 
trends. 
 
7. National Role 
 
The Chair continues to serve as a member of the Robert Wood Johnson (RWJ)-sponsored 
Partnerships for Quality Education National Advisory Committee.  This committee with 
members from AHIP, the NCQA, and other national bodies continues to provide oversight 
to the multi-year, $12 million RWJ-funded program.  The Chair led a site visit this year to 
one of the grantees at the University of Cincinnati School Of Medicine.  The Chair also 
serves as a principal advisor to the Tufts Health Care Institute (THCI) in Boston, 
Massachusetts. 
 
8. American College of Physician Executives 
 
Other innovative curricular material included the further refinement of the American 
College of Physician Executives (Tampa, Florida) sponsored web-based course titled, 
“Interact”.  The Chair produced and filmed an updated two-CD course titled, “The Three 
Faces of Quality”, for physician executives throughout the United States.  It continues to 
be offered eight times per year in an asynchronous fashion through a secure web site with 
streaming video and simultaneous full printed text of the lectures.  The online classroom 
experience is facilitated by the Chair and two additional nationally prominent faculty 
members.  Comprehensive surveys indicate that this course is very well received.  The 
Chair also completed five new online CME approved lectures for the Graduate Education 
Foundation (GEF) in Philadelphia. The lectures included material focused on quality 
measurement and improvement.  Several of the GEF lectures are being marketed nationally 
to residency program directors in fulfillment of the ACGME competencies. 
 
9. Continuing Medical Education 
 
The Department continued to have an outstanding relationship with the Office of 
Continuing Medical Education.  The Department continues to provide the second highest 
grossing CME activity within JHS.  This year the Chair continued to support the 
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innovative Jefferson Advisory Council (JIAC), the activities of which are described above.  
The Chair has served as a voting member the JMC-CME Committee for the last eight 
years. 
 
10. Continuing Pharmacy Education 
 
The Department serves as an approved provider of continuing education for pharmacists.  
The Department is the only approved provider on campus and works closely with other 
departments to maximize their continuing education programs.  The Department was 
successfully reaccredited to provide CE to pharmacists through the American Council on 
Pharmaceutical Education. 
 
11. Future of Educational Programs 
 
The Department will continue to offer a diverse range of programs across the medical 
education curriculum and to other regional and national audiences.  Several opportunities 
for increased involvement and support of JMC’s efforts exist and will continue to be 
explored. 
 
On the undergraduate level, the Interclerkship Day on patient safety was extremely well 
received and the program is being revised for January 2006.  We recognize that 
undergraduates would benefit from more exposure to non-traditional subjects such as 
health policy, quality improvement, error reduction, evidence-based practice, and public 
health.  We will work with JMC leadership to explore other opportunities, such as 
assuming responsibility for an additional Interclerkship Day. 
 
Opportunities also exist to expose residents to these same topics and issues on the graduate 
education level.  The Department will seek opportunities to work with residency program 
directors to see that the new ACGME requirements are adequately addressed in the 
curriculum.   
 
Finally, we will continue to support the Medical College’s faculty development program 
by offering support for training programs on policy, performance measurement and 
improvement and other relevant topics. 
 
 
B.  Research 
 
1) Current projects 
 
The Department’s research program covers a wide range of topics and methodologies.  At 
any one time, an average of 25 active projects are being conducted by the Department’s 
research staff, under the direction of Mr. Neil Goldfarb, Director of Research, and Laura 
Pizzi, PharmD, MPH, Associate Director of Research.  In the 2004-2005 academic year, 
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active projects had direct cost budgets summing to $2.6 million.  The project funding 
profile during this time was approximately 20% government grants (up 5% from the 
previous year), 50% pharmaceutical industry-sponsored research, 10% foundation grants, 
and 20% other sources (biotech industry, managed care and insurance, etc.).   
  
The Department has always sought to serve as a research partner and support for other 
investigators within the Jefferson community.  In the 2004-2005 academic year, 
Department research staff worked on projects and proposals with faculty and research staff 
from Endocrinology, Infectious Disease, General Internal Medicine, Family Medicine, 
Psychiatry, Gastroenterology, Neurology, Emergency Medicine, and Cardiology.  A 
summary of current projects (as of September 2005) is provided on the next page 
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Department of Health Policy, Summary of Current Research Grants, September 2005 
 
Title Investigators Source of Support Total 
Amount 
College for the Advanced Management 
of Health Benefits (2005) 
N. Goldfarb, C. 
Hartmann, D. Nash 
HealthCare21 
Business Coalition 
$60,000 
Cost Identification Study for 
Complicated Inpatient Infections 
C. Hartmann, V. Maio, 
N. Goldfarb, D. Horn 
(Infectious Disease) 
Wyeth $136,561 
Predictive Model Development for Pain 
Medication Utilization in Hospice Care 
N. Goldfarb, L. Pizzi ExcelleRx $47,550 
Evaluation of Disease Management 
Interventions 
D. Nash, N. Goldfarb, 
A. Crawford, J. Clarke 
American 
Healthways 
$400,000 
Evaluation of Patient-oriented 
Interventions to Improve Quality of Care 
A. Crawford, N. 
Goldfarb, D. Nash 
Horizon Blue Cross 
Blue Shield 
$109,157 
Tailored Messages to Improve Cancer 
Prevention (K Award) 
C. Sciamanna NCI $213,854 
Tailored Messages to Improve Physical 
Activity 
C. Sciamanna NHLBI $1,337,440
Evaluation of On-line Continuing 
Medical Education for Physicians 
D. Nash, C. 
Sciamanna,  
Graduate Education 
Foundation 
$102,000 
Economic Analysis of Productivity Data 
from the Topamax Trial 
L. Pizzi, J. Lofland,  
K. Smith 
OrthoMcNeil 
Janssen 
$53,597 
Development of a National Quality 
Measurement Set for Migraine  
N. Goldfarb, D. Nash, 
J. Lofland, S. 
Silberstein (Neurology) 
OrthoMcNeil 
Janssen 
$439,503 
Cost Identification Study for Inpatient 
Candidal Infections  
V. Maio. C. Hartmann, 
N. Goldfarb, D. Horn 
(ID) 
MediMedia/Pfizer $87,908 
Relationships between Changes in 
Glycemic Control and Changes in 
Pharmacotherapy for Diabetes 
K. Smith, N. Goldfarb GSK $108,589 
Economic Impact of Breakthrough Pain L. Pizzi, N. Goldfarb Cephalon $192,849 
Measurement of Productivity Loss 
Associated with Overactive Bladder  
L. Pizzi, J. Lofland,  
K. Smith 
Watson $119,983 
Research Awards Program for the IAQ 
Instrument 
L. Pizzi, N. Goldfarb BMS $100,000 
Evaluation of On-site Pharmacy Access 
for Community Health Centers 
V. Maio, L. Pizzi, 
N. Goldfarb 
Health Federation 
of Philadelphia 
 
$20,000 
Economic Modeling of Iron Replacement 
Therapy for Dialysis Patients 
L. Pizzi, N. Goldfarb Watson 
Pharmaceutical 
$68,774 
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Title Investigators Source of Support Total 
Amount 
Economic Modeling Training Program 
and Evalution 
N. Goldfarb, L. Pizzi AstraZeneca $128,250 
Impact of Performance Improvement 
Modules in a Group Practice Plan 
N. Goldfarb,  
A. Crawford, D. Nash 
American Board of 
Internal Medicine 
$10,000 
Impact of GetWellNetwork on 
Handwashing Behavior in Inpatient Care 
C. Sciamanna, D. Nash GetWellNetwork $ 75,000 
 
 
Other projects, completed in the 2004-2005 academic year, included: 
 
• Validation study for the Diabetes Management Evaluation Tool (DMET), an 
instrument for assessing patient experience with diabetes disease management 
programs 
• Evaluation of the use of B-type Natriuretic Peptide (BNP) as a heart failure 
screening test in a primary care practice 
• National employer survey regarding interest in and experience with value-based 
purchasing 
• Case studies of 18 exemplary value-based purchasing programs 
• Evaluation of the use of interactive voice recognition software to improve 
preventive care behaviors in a managed care population 
• Economic analysis of the use of wireless capsule endoscopy in diagnosing Crohn’s 
disease 
• National survey of managed care medical directors regarding attitudes toward 
asthma diagnosis and treatment 
• Policy analysis of alternative approaches to utilization management for 
pharmaceuticals for the elderly 
• Policy analysis of access to atypical anti-psychotics in the Medicaid program 
• Policy analysis of barriers to use of minimally-invasive surgical techniques 
• Identification of the barriers to early insulin use in treating Type II diabetes 
• Review of systems to improve access to care in the Pennsylvania Medicaid 
program for clients with physical disabilities 
• Quality of life survey for patients with inflammatory bowel disease 
• National survey of disease management programs for schizophrenia 
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2) Departmental publications 
 
a. P&T 
 
The Department completed its sixth full year as editor and continuing education 
provider of P&T, a nationally recognized peer-reviewed journal concerned with all 
aspects of pharmaceutical use and care.  P&T has a national monthly circulation of 
nearly 60,000.  The Editorial Board of the journal was continuously updated, 
bringing in persons from the pharmacoeconomic research world as well as from 
disease management firms.  The Chair continues to write a monthly editorial for 
P&T.  These editorials are often reprinted elsewhere and garner a nationwide e-
mail response on a regular basis.   
 
b. Disease Management 
 
The Department also continued its editorial directorship for Disease Management, 
the only peer-reviewed journal in the disease management field. The journal 
continues to be recognized through acceptance in MEDLINE and Index Medicus.  
The Editorial Board consists of more than 65 persons across the United States in 
such fields as managed care, the pharmaceutical industry, the disease management 
industry, epidemiology, and public health.  Disease Management increased its 
publication schedule, now publishing bimonthly and reaching a paid national 
circulation of over 1,200.  Disease Management is the official journal for the 
Disease Management Association of America (DMAA), the leading national 
organization concerned with the public policy issues in disease management.  The 
Chair is also a member of the Board of Directors of the DMAA, which has evolved 
to be the gold standard for research in this burgeoning field.  The Editorial Board of 
the journal held its annual in person meeting during the DM Colloquium, hosted by 
the department. 
 
c. Biotechnology Healthcare 
 
The Department continued to serve as the editorial home for, Biotechnology 
Healthcare, a controlled circulation publication focused on the socioeconomic and 
political issues in the burgeoning field of biotechnology with an emphasis on the 
human genome.  It has a circulation of 35,00 persons across the nation and is 
currently distributed quarterly.  A 70-person Editorial Board was assembled by the 
Department and these individuals represent leaders from every sector within the 
biotechnology arena, including bioethics, law, the basic sciences, public policy, and 
the pharmaceutical industry.  The Editorial Board of the journal held its annual in 
person meeting during BIO2005, a major national biotechnology conference in 
Philadelphia. 
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d. American Journal of Medical Quality 
 
The Chair has completed one full year as editor for the 20-year old peer-reviewed 
journal entitled, American Journal of Medical Quality, the official journal of the 
American College of Medical Quality (ACMQ) headquartered in Bethesda, 
Maryland.  As the national conversation regarding the measurement and 
improvement of health care quality and patient safety  evolves, it is clear that 
AJMQ is poised to play a leadership role.  As such, the Chair, in his role as Editor-
in-Chief, completely transformed the editorial board which now consists of over 95 
leaders from around the country.  AJMQ is also closely affiliated with the 
University Healthsystem Consortium (UHC) in Chicago, Illinois as the Chair 
recruited their leadership to host a monthly column in the journal.  Works of 
constituent members within the UHC is regularly featured in AJMQ, such as the 
winning submissions in their annual quality contest. 
 
e. Health Policy Newsletter 
 
The HP Newsletter is now in its fourteenth year of publication, serving as an 
important part of the TJU commitment to disseminate information on health policy.  
The newsletter is sent on a complimentary basis to all physicians and senior 
administrators throughout the JHS and is delivered quarterly with the Jefferson 
Alumni Bulletin.  In addition, the newsletter has more than 25,000 subscribers 
throughout the world and has been distributed at dozens of national medical 
meetings.  Editorials from the newsletter are often reprinted in other publications.  
“Letters to the Editor” indicate widespread readership of the newsletter, especially 
among JMC alumni.  Once again, the Department would gratefully like to 
acknowledge the support of Max Koppel, MD, MBA, MPH (JMC ’57), who has 
generously continued to provide additional resources to help defray the cost of the 
newsletter’s publication. 
 
f. Texts 
 
Scholarly publication in the Department is also focused on edited multi-authored 
texts.  During this past year, the Department signed two new book contracts with 
Jones and Bartlett, a respected medical publisher.  The two new texts include one 
focused on quality improvement and patient safety, while the other is focused on 
economic evaluation in healthcare.  The two texts (published in the fall of 2005), 
The Quality Solution and Economic Evaluation in US Health Care: Principles and 
Applications, will serve as the core reference materials for two of the Department 
courses in the TJU-MSPH program. 
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g. Additional notes 
 
DHP publications have appeared in numerous peer-reviewed journals, newspapers, 
magazines, videotapes, audiotapes, CDs, and web casts.  These are all available for 
review in the Department.  The DHP website (www.jefferson.edu/dhp) is 
continually updated and received nearly 2000 hits per month.  The Chair continued 
to serve on the editorial boards of nine peer-reviewed journals as well as the Editor-
in-Chief of P&T, Disease Management, Biotechnology Healthcare, and American 
Journal of Medical Quality. 
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3) Scientific presentations 
 
The work of the staff has continued to garner national press attention with more than three 
dozen stories and interviews appearing in such publications as Modern Healthcare, The 
Philadelphia Inquirer, Modern Physician, Health Leaders, The Wall Street Journal, 
MGMA Connexion, and Disease Management News.  Scientific presentations made by 
Department faculty and staff in 2004-2005 include: 
 
Crawford AG, Roco C, Riggio J, Valko G, Goldfarb NI, and Nash DB.  "Patient 
Education and Adherence and Hypertension Control in Two Academic Medical 
Center Primary Care Practices."   Poster presentation at the Tenth Annual 
Meeting of the International Society for Pharmaco-economics and Outcomes 
Research, May 16, 2005.  Poster published as Crawford AG, Roco C, Riggio J, 
Valko G, Goldfarb NI, and Nash DB.  "Patient Education and Adherence and 
Hypertension Control in Two Academic Medical Center Primary Care Practices." 
Value Health 2005;8. 
 
Gelb Safran D, Thier SL, Wilson I, Bender W, Sommers T, Chang H, Rogers WE. 
Treatment Nihilism: Exploring Attitudinal Factors that may Contribute to 
Disparities in Health Care. Presented at 28th Annual Meeting of the Society 
of General Internal Medicine May 2005. 
 
Gelb Safran D, Thier SL, Wilson I, Bender W, Sommers T, Chang H, Rogers WE. 
Treatment Nihilism: Exploring Attitudinal Factors that may Contribute to 
Disparities in Health Care. Presented at AcademyHealth Annual Research 
Meeting June 2005. 
Goldfarb NI, Pizzi LT, Fuhr JP, Salvador C, Sikirica V, Kornbluth, A, and Lewis B. Role 
of Wireless Capsule Endoscopy in the Diagnosis of Crohn’s Disease: An Economic 
Analysis. (Abstract No. 107314) Poster Presentation at Digestive Disease Week, New 
Orleans, Louisiana, May 2004.  
 
Goldfarb NI.  Economic Analysis for Video Capsule Endoscopy.  International Conference 
on Capsule Endoscopy, Miami FL, March 2005 
 
Goldfarb NI, Hartmann C.  What Can We Learn from the Value-Based Purchasing Pioneers?  
Podium presentation at the National Business Coalition on Health Annual Conference, 
Atlanta GA, November 2004 
 
Patel N, Goldfarb N, Hartmann CW, Maio V, Horn DL, and Pizzi L. Impact of 
complicated skin and soft tissue infections on inpatient costs for an academic medical 
center. Poster presentation at the 10th Annual Meeting of the International Society for 
Pharmacoeconomics and Outcomes Research,  Washington DC, May 2005. 
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Pizzi LT, Gemmen E, Dahl NV. Characteristics Related To Productivity Loss In Patients 
With Overactive Bladder: Results From The MATRIX Study. Podium presentation 
accepted for the 8th Annual Congress of the International Society for Pharmacoeconomics 
and Outcomes Research, Florence, Italy, November 2005. 
 
Salvador CG, Sikirica M, Evans A, Pizzi LT, Goldfarb NI. Clinical and Economic 
Outcomes of Patients with Prolonged Postoperative Ileus Undergoing Hysterectomy and 
Hemicolectomy at an Academic Medical Institution.  Poster presentation at the American 
Society of Health-Systems Pharmacists Midyear Clinical Meeting, Orlando FL, December, 
2004.  
 
Sciamanna CN, Miller ER, Manocchia M, Mui S, Sciamanna AN. Internet-based, 
personalized, patient activation feedback to improve hypertension guideline 
adherence does not harm patient perceptions of care. Poster presentation at Academy 
Health, Boston, MA, June 2005. 
 
Sciamanna CN, Nicholson RA, Lofland JH, Manocchia M, Mui S, Hartmann CW. 
Effects of a website designed to improve patient-provider interactions for 
the management of migraines. Poster presentation at Academy Health, Boston, MA, June 
2005. 
 
Weston C, Sikirica V, Pizzi L, Goldfarb N, Moretti D, Cobb N, Howell J, Infantolino A, 
DiMarino A, Cohen S. Work Loss and Activity Impairment Due to Inflammatory Bowel 
Disease. Podium presentation at the 9th Annual Meeting of the International Society for 
Pharmacoeconomics and Outcomes Research, Crystal City VA, May 2004. 
 
Weston C, Poston S, Pizzi L, Goldfarb N, Sikirica V, Reifsnyder J, and Maxwell T. Opioid 
use in a large national hospice population: Examination of cancer versus non-cancer 
patients. Poster presentation at the 10th Annual Meeting of the International Society for 
Pharmacoeconomics and Outcomes Research,  Washington DC, May 2005. 
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4) Research Faculty Strengths 
 
The Department’s research portfolio demonstrates diversity with regard to research 
methodologies, clinical areas, settings, perspectives, and relevance to local and national 
health policy.  Among the specific strengths that have been identified by the Department’s 
research faculty are: 
 
• Performance (quality) measurement and improvement in health care 
• The employer’s role in health care/value-based purchasing 
• Disease management program implementation and evaluation 
• Patient-provider communications and behavior modification 
• Economic analysis: cost identification, modeling, and pharmacoeconomics 
• Outcomes measurement, including quality of life, and productivity 
• Evaluation of health care technologies (drugs, devices, programs)  
• Market research/development of marketing strategy 
• Critical literature evaluation and evidence-based medicine 
• Health policy research: description, analysis and evaluation of policy 
alternatives 
• Evaluation of outcomes in specific clinical areas (e.g. diabetes, migraine, 
gastroenterology) 
• Health informatics and the Internet in medicine 
 
5) Areas for Faculty Development 
 
As the Department continues to develop, faculty will be sought with skills in the following 
areas, to improve on the collective expertise and increase the ability to obtain external 
funding: 
 
• Predictive modeling, artificial intelligence, and neural networks in health care 
• Health economics 
• Biostatistics and Epidemiology 
• Survey research methodology 
• Evidence based medicine methodology, e.g. meta-analysis 
• AMCP formulary dossier development 
 
6) Future Funding Potential 
 
The Department has grown almost entirely through extramural grant support for research 
and education programs.  Both for the short term and longer time horizon, we are 
projecting an increased ability to obtain funding, as we convert research staff to 
independent investigators and recruit additional faculty.  As a generalist shop with 
expertise and experience in health policy, health services research, and pharmaceutical 
 30
outcomes research, we do not have a narrow range of research programs or lines of 
investigation.  Some of the more promising avenues of research which are being nurtured 
currently include: 
 
• Quality measurement and improvement in the ambulatory care setting (D. Nash, N. 
Goldfarb, A. Crawford) 
• Improving physician-patient communications and overcoming cultural barriers (C. 
Sciamanna, C. Hartmann) 
• Economic evaluation of health care technologies (drugs and devices) (L. Pizzi, N. 
Goldfarb, V. Maio, K. Smith) 
• Measurement of workplace productivity (J. Lofland, L. Pizzi) 
• Supporting the employer’s role in quality improvement (N. Goldfarb, D. Nash, C. 
Hartmann) 
• Appropriateness and cost-effectiveness of prescribing (V. Maio, L. Pizzi, C. 
Hartmann) 
• Evaluation of electronic medical records and other e-health interventions (C. 
Sciamanna) 
 
7) Plans for next two years 
 
Our key research goal is to continue to build the number and size of grants, and diversify our 
portfolio, especially with regard to federal grants (which carry increased national recognition 
and greater indirect cost recovery).  We have several objectives which will help to achieve this 
goal: 
 
• Identify and build on track records of faculty and senior researchers in existing areas of 
expertise, e.g. pharmacoeconomic evaluation, methods for measuring and improving 
quality of care, measurement of productivity, fostering the employer and consumer roles 
in quality 
 
• Encourage junior faculty (current research staff who are now seeking faculty 
appointments) to pursue federal training grants (e.g. K-awards) and other post-doctoral 
grant opportunities 
 
• Recruit faculty with existing support and/or track record in obtaining research support 
from foundation and federal sources 
 
• Return to current and previous sponsors to seek additional project funding and continue 
building a research trajectory  
 
• Develop an expectation that all faculty apply for at least one federal grant per year 
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C.  Patient Care  
 
The Department of Health Policy does not have a clinical practice base.  Drs. Nash and 
Sciamanna, the two physicians in the Department, both maintain their clinical skills 
through patient care in the Division of General Internal Medicine. 
 
The Department also is leading Jefferson University Physicians’ performance 
measurement and improvement efforts.  Dr. Nash chairs the JUP Clinical Care Committee, 
and Neil Goldfarb was appointed JUP’s Director of Ambulatory Care Performance 
Improvement in 2005.  Additional Departmental staff working on JUP initiatives include 
Cecilia Roco, RN, CDE, (funded 100% by JUP), Al Crawford, PhD, MBA, MSIS (funded 
50% by JUP), and Howard Chapman (funded 50% by JUP).  Departmental outcomes 
research fellows also participate in JUP departmental initiatives.  Performance 
measurement work is underway in almost all JUP departments.  A “Celebrate the Gains” 
program was scheduled for September of 2005 to spotlight the Clinical Care Committee’s 
work, and included presentations from six of the participating departments.   
 
For the remainder of 2005-2006, the goal is to continue to foster each department’s efforts 
to measure and improve performance for at least one key quality indicator.  In addition, the 
JUP agenda is expanding to include an increased activity related to primary care quality 
measurement and aligning JUP’s performance improvement activities with national 
initiatives including pay for performance programs.  A collaborative project with the 
American Board of Internal Medicine will evaluate the use of the ABIM’s Performance 
Improvement Module (PIM) project in academic group practice.  JUP also will participate 
in the pilot test of the University HealthSystem Consortium (UHC) Ambulatory Care 
Measurement Set, beginning with an evaluation of quality of care for people with diabetes.    
 
D.  Affiliations 
 
The department maintains a wide range of affiliations both within the Jefferson 
community and in the broader local, regional, and national health care systems.  
 
Largely as a result of our multiple research projects and our work with the JUP-
CCC, we have robust interdepartmental connections with nearly every clinical 
department on the campus.  Staff from the Department of Health Policy work with 
faculty, and others, from every clinical department to support the quality 
measurement agenda for JUP.  Through service as a data, analytic, and education 
resource, the Department provides value-added health care consulting to JMC and 
TJUH and, to some extent, the JHS.  The Chair serves as a founding member of the 
Quality Council chaired by Stanton N. Smullens, MD, the CMO of JHS.  Other 
aspects of the consulting mission are expressed through the Chair's service on the 
hospital's Pharmacy and Therapeutics Committee (a position he has held for 15 
years) and on the JHS Pharmacy Task Force.  In addition, he chairs the Quality 
Medication Subcommittee of the P&T Committee.  The Chair also serves on the 
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TJUH Clinical Performance Improvement Committee.  Also, he was appointed to 
the TJUH PEACE Committee (Pharmacoeconomics and Cost Effectiveness).  
Finally, the Chair was named to the Albert Einstein Health System Urban Health 
Policy Institute Advisory Board. 
 
This year, the Department’s Health Policy Senior Scholars Program, which 
recognizes individuals who make a commitment to the Department to participate, 
in a modest way, in our ongoing research and educational activities, grew its 
membership to over 45 local, regional and national leaders in industry and 
academia. 
 
On a state level, the Department has an ongoing research affiliation with the 
Pennsylvania Health Care Cost Containment Council (PHC4), and Dr. Nash also 
chairs the PHC4 Technical Advisory Group (TAG).  The PHC4 has continued to 
publish statewide outcomes reports on coronary artery bypass graft surgery, the 
care of persons with diabetes mellitus, the quality of care in HMOs throughout 
Pennsylvania, and for the first time, a hospital and physician specific report on hip 
and knee surgery.  Several front-page Philadelphia Inquirer and Business Journal 
stories have resulted from the efforts of PHC4 and the TAG.   
 
The Chair maintained a large number of consultancies with firms in the private 
sector; especially those concerned with E-Health and E-Commerce.  For example, 
the DHP completed the fifth year of a strategic planning project with GE Medical 
Systems.  The Chair also leads the GE-MedicaLogic Quality Improvement 
Consortium (MQIC), a national group of 1,000 physician electronic medical record 
users. 
 
In addition, the Chair consulted with firms such as Future Health, MedCases and 
GetWell Network.  He was named to the Board of Directors of the Itrax 
Corporation (DMX:  Amex), a disease management firm, and he also chairs the 
Board Nominating Committee  These private sector initiatives provide important 
additional sources of external support as well as relevant databases for the research 
mission of the Department.  Finally, the Department continues as a part of the 
American Healthways (AMHWS) National Outcomes Verification program.  
AMHWS is the largest publicly held disease management company in the country.  
All relevant conflict of interest forms and confidentiality statements are on file with 
the Office of the University Counsel. 
 
On a national policy level, the Department has greatly increased its participation in 
the debate surrounding quality measurement and management.  This was achieved, 
in part, by the Chair's personal involvement with numerous professional societies in 
the following capacities: 
 
• Continued membership (since 1995) on the Advisory Council on Performance 
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Measurement (ACOPM) of the Joint Commission on Accreditation of Health Care 
Organizations (JCAHO), which oversees the national ORYX measurement 
initiative. 
• Continued 11th year as Chairman of the IMS (Plymouth Meeting, 
Pennsylvania) sponsored National Disease Therapeutic Index (NDTI).  This is an 
internationally regarded, physician-specific, pharmacy-tracking program. 
• Membership in the National Quality Forum (NQF) and the Council on 
Research and Quality Improvement.  The Chair was also appointed to direct the 
NQF Technical Advisory Panel on guidelines for ambulatory pharmaceutical 
management. 
• Continued membership on the Board of Trustees of Catholic Health Care 
Partners (CHP), the tenth largest non-profit integrated delivery system in the 
country, headquartered in Cincinnati, Ohio.  The Chair continued as the Chairman 
of the CHP Board Committee on Quality and Safety.  He is regularly invited to 
address quality-related issues for many of the constituent institutions of the CHP 
and he was a part of a CHP Board Retreat to Dublin, Ireland in October 2004. 
• Membership on the University of Oregon RWJ-sponsored project on 
improving the Consumer Assessment of Health Plan Survey Tools (CAHPS). 
• The Chair was appointed to the Medical Leadership Council (MLC) of the 
UHC and the MLC Executive Committee – a key group of physicians who help to 
set quality improvement strategies for the UHC. 
 
Through membership in activities sponsored by such groups as the JCAHO, NDTI, 
NQF, CHP, and the UHC, the Department is at the center of major national 
programs involved in measuring and improving health care quality. 
 
The Department also continues its involvement with the International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR).  This year, ISPOR marked its 10th 
Anniversary and the Department was recognized as an ISPOR Annual Meeting sponsor for 
10 consecutive years. ISPOR continues to be an important venue for research related to 
pharmacoeconomics and outcomes research.  Laura Pizzi served as a session moderator 
during the Annual Meeting and was recently invited to join the ISPOR Workgroup on 
patient registries.   
Finally, the 11th annual DHP Summer Retreat was held on July 15, 2005, with a 
special focus on Payment for Performance (P4P).  Nationally prominent individuals 
from the National Business Coalition on Health (NBCH), the Joint Commission on 
Accreditation of Healthcare Organizations (JCAHO), CIGNA, and others 
participated in a full day program.   The retreat attracted nearly 175 persons 
representing more than 50 different regional organizations.  The Summer Retreat is 
offered as an educational service to the scores of research clients and professional 
colleagues in the Delaware Valley. 
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E.  Interdepartmental Programs 
 
The Department’s research and education activities involve collaboration with a wide 
range of Jefferson departments, as discussed above.  In brief, these collaborations have 
included: 
 
• Performance measurement activities with all JUP Departments 
• Co-direction of the MSPH program with the Department of Family Medicine 
• Collaborative research projects with the Department of Family Medicine, the 
Division of Gastroenterology, the Division of Infectious Diseases, Department of 
Psychiatry, Department of Emergency Medicine, Department of Neurology, and 
Division of General Internal Medicine 
• Collaborative education programs with: the Dean’s Office; Departments of 
Anesthesiology, Dermatology, Emergency Medicine, Family Medicine, Internal 
Medicine, Neurology, Nursing, Nutrition and Dietetics, OB/GYN, Occupational 
Health, Pathology, Pharmacy, Psychiatry, Radiation Oncology, Radiology, 
Surgery, and Urology; Divisions of Cardiology, Gastroenterology, Hepatology, and 
Infectious Disease; the Kimmel Cancer Center; the Jefferson Pain Center; and, the  
Rothman Institute 
• Participation in the TJU Strategic Planning Initiatives, with Departmental faculty 
serving as committee members to evaluate the possibility of a School of Public 
Health (J. Lofland, PhD and the Chairman), and School of Pharmacy (L. Pizzi), and 
to develop a service and operational excellence dashboard (N. Goldfarb).  The 
Chair also served as a resource for many of the strategic planning committees and 
leadership.   
y The DHP has been collaborating since 2001 with the Center for Research in 
Medical Education and Health Care in a major series of projects supported 
by the Regional Health Care Agency of the Emilia-Romagna Region of 
Italy.  These projects address a wide range of issues in health care 
organization, financing, and quality improvement activities.  Ongoing 
activities include: development of a longitudinal, population-based, health 
care utilization database including the four million residents of the region; 
refinement and validation of a method for assessing the timelines and 
appropriateness of acute hospitalization; risk adjustment models to assist in 
health care planning and financing at the local level; assessment of 
appropriateness of outpatient prescription use; and analysis of the impact of 
prescription drug co-payments on patterns of drug use and patient outcomes.  
 
F.  Faculty 
 
As discussed above, the new Department is just beginning to develop a faculty, building 
both on current senior research staff, and recruitment of additional researchers.  Strengths 
and weaknesses are identified above.  We remain confident in our ability to create a core 
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group of research faculty who will help to propel us successfully into the future as a more 
mature Department of Health Policy amongst our national peer group.  In July of 2005, the 
Department Chair and Director of Research met individually with each faculty member for 
an annual performance review, and setting of goals for 2005-2006.  Departmental 
expectations of faculty were reviewed at these meetings, and each faculty member has 
developed an action agenda for meeting these expectations.  Evaluation of the impact of 
these efforts will be conducted in the summer of 2006.   
 
G.  Departmental Administration 
 
The hiring of David Glatter, MBA, as Departmental Administrator, in July of 2005, will 
help the Department meet its growing administrative and grants management 
responsibilities.  The administrative team for the Department also includes a Grants 
Manager, an Office Manager, and two Administrative Assistants.  This staff serves the 
administrative needs of the entire Department, including the Chair and faculty, and 
manages the portfolio of over 40 grants at any one time (including 25 research grants).  
The Department Chair meets monthly with the Directors of Research and Education, the 
Office Manager, and the Grants Administrator, to review financial reports and discuss 
administrative issues.  The Department Chair, Departmental Administrator, and the 
Directors of Research and Education compose the Department’s “Steering Committee” and 
meet weekly to discuss strategy, staffing, new business development, and project 
management issues.   
 
H.  College-level issues 
 
From the Chair’s perspective, the most important departmental issue at the college level is 
core support for young research faculty and the need for more office space.  As we seek to 
recruit research faculty with partial support, we need a modest level of external resources 
to nurture them into the senior ranks of the faculty.  In addition, we need appropriate office 
space for their activities including space for support staff such as research assistants, and 
the like. 
 
Additional issues that need to be addressed at the college level include faculty status for 
non-clinical, non-basic science individuals who are devoted to a career in health services 
research.  Most large medical schools have appropriate faculty level recognition for such 
individuals.  This should be further codified at JMC. 
 
Finally, the methodology used for interdepartmental billing and collection lacks adequate 
managerial controls.  The current system is akin to giving one’s personal credit card to a 
stranger and awaiting the ensuing bills.  This lack of accountability and transparency 
makes it extremely difficult to adequately plan during each budgetary cycle.  In addition, 
the relatively arcane accounting principals endorsed by TJU proper contribute to this lack 
of managerial control at the departmental level.  Hopefully, pending changes in the rules 
recently promulgated by TJU proper will ameliorate this problem. 
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In summary, the Department of Health Policy has made significant strides in the past year 
to adapt its programs and strategies to the newly-conferred departmental status.  We are 
excited about the progress already made, and our contributions to the Medical College’s 
mission and the national policy debate.  We look forward to expanding the scope of 
activities and their impact in the years ahead. 
 
 
